Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

2021; Elsevier BV; Volume: 22; Issue: 4 Linguagem: Inglês

10.1016/s1470-2045(21)00007-3

ISSN

1474-5488

Autores

Martine Piccart, Laura van ′t Veer, Coralie Poncet, Josephine Lopes Cardozo, Suzette Delaloge, Jean‐Yves Pierga, Peter Vuylsteke, Étienne Brain, Suzan Vrijaldenhoven, Peter A. Neijenhuis, S. Causeret, Tineke J. Smilde, Giuseppe Viale, Annuska M. Glas, Mauro Delorenzi, Christos Sotiriou, Isabel T. Rubio, Sherko Kümmel, Gabriele Zoppoli, Alastair M. Thompson, Erika Matos, Khalil Zaman, Florentine Hilbers, Debora Fumagalli, Peter M. Ravdin, Susan Knox, Konstantinos Tryfonidis, Aleksandra Peric, Bart Meulemans, Jan Bogaerts, Fátima Cardoso, Emiel J. Rutgers,

Tópico(s)

Advanced Breast Cancer Therapies

Referência(s)